Waterford’s EirGen Pharma partners with South African firm.  EirGen Pharma, currently on an Enterprise Ireland trade mission to South Africa, has secured a significant partnership agreement with South African pharmaceuticals company Equity Pharmaceuticals to develop and commercially supply five oncology products from its Waterford facility.  7th November, 2011. Read more...

LINK Healthcare announces it has been granted a licence to market Relistor® (methylnaltrexone) in Australia, New Zealand, South Africa and Asia from Salix Pharmaceuticals, Inc. of North Carolina, USA. 19th October, 2011. Read more...

LINK Pharma has received marketing approval in both Australia and New Zealand for "ANAPEN 500," a 500 microgram adrenaline auto-injector. 29th September, 2011. Read more..

LINK Pharma has acquired a range of adrenaline products previously sold by Astra Zeneca Australia. 29th June, 2011 .Read more...

Gentium S.p.A. announced the appointment of LINK Pharmaceuticals as exclusive distributor of Defibrotide in Australia and New Zealand. June 15, 2011. Read more...

Stallergenes obtains a marketing authorisation for Oralair® in Australia. 18 May, 2011. Read more...